Heparin monitoring in sheep by activated partial thromboplastin time

被引:7
|
作者
Park, SG
Kim, SC
Choi, MJ
Lee, HS
Min, BG
Cheong, J
Lee, K [1 ]
机构
[1] Cheju Natl Univ, Dept Vet Med, Coll Agr, Jeju, South Korea
[2] Cheju Natl Univ, Inst Artificial Heart, Coll Agr, Jeju, South Korea
[3] Hanmaeum Gen Hosp, Dept Thorac & Cardiovasc Surg, Jeju, South Korea
[4] Cheju Natl Univ, Dept Med, Sch Med, Jeju, South Korea
[5] Seoul Natl Univ, Interdisciplinary Program Biomed Engn Major, Coll Engn, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Inst Med & Biol Engn,Med Res Ctr, Seoul, South Korea
关键词
heparin; activated partial thromboplastin time; platelet count; sheep;
D O I
10.1046/j.1525-1594.2003.07090.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Heparin anticoagulation is utilized during and after vascular surgery in animals to reduce the risk of acute or chronic thromboembolic problems. In this study, we examined variation of activated partial thromboplastin time APTT) after the intravenous bolus IV bolus) and subcutaneous SC) heparin injection in order to monitor heparin therapy in sheep. Nine healthy sheep were assigned to 3 groups A, B, and C) according to their body weights: less than 40 kg, 40 to 80 kg, and more than 80 kg, respectively. All animals were treated with heparin 300 IU/kg body weight) through two routes, and the APTT, fibrinogen, and platelet count were measured before and every hour after treatment. This showed that the APTT was increased significantly between 1 to 4 hours after IV bolus injection and between 2 to 6 hours after SC injection P < 0.05). The APTT was returned to baseline values 6 and 10 hours after the respective treatments. The APTT in Group C was consistently higher than in Group A and B after heparin treatment by the two routes. The APTT ratio entered the subtherapeutic range 5 and 8 hours after IV bolus and SC injection, respectively. The APTT ratio was maintained in the therapeutic range for about 1 and 4 hours after IV bolus and SC injection, respectively. The highest APTT ratio in Group C after SC injection of heparin was significantly higher than that in Groups A and B P < 0.05). The mean platelet counts in Groups A, B, and C before the injection were 3,197 +/- 365.6, 2,886 +/- 78.2, and 1,861 +/- 298.0 10(2) /muL, respectively. The mean platelet count gradually decreased without significant variation after IV bolus and SC injection. These results produced elementary data for monitoring in sheep using APTT, and suggested that heparin should be administrated by the SC route at 4-hour intervals in order to remain in the therapeutic range, after an initial IV bolus dose.
引用
收藏
页码:576 / 580
页数:5
相关论文
共 50 条
  • [21] MONITORING OF HEPARIN-THERAPY BY THROMBIN CLOTTING TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME - A COMPARISON
    LANG, M
    FEY, MF
    FURLAN, M
    BECK, EA
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 116 (48) : 1681 - 1684
  • [22] Evaluation of a bedside device to assess the activated partial thromboplastin time for heparin monitoring in infants
    Klein, Richard H.
    van der Vorst, Marja M. J.
    de Wilde, Rob B. P.
    Hogenbirk, Karin
    de Kam, Marieke L.
    Burggraaf, Jacobus
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (03) : 327 - 331
  • [23] MONITORING OF HEPARIN-THERAPY WITH THE ACTIVATED PARTIAL THROMBOPLASTIN TIME AND CHROMOGENIC SUBSTRATE ASSAYS
    FEY, MF
    LANG, M
    FURLAN, M
    BECK, EA
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (03) : 853 - 855
  • [24] Monitoring Unfractionated Heparin: A Review of Activated Partial Thromboplastin Time Versus Antifactor Xa
    Parker, Christine R.
    Kataria, Vivek
    AACN ADVANCED CRITICAL CARE, 2019, 30 (04) : 305 - 312
  • [25] Antifactor Xa levels compared to activated partial thromboplastin time for heparin monitoring.
    Coons, James
    Whitman-Purves, Emily
    Pae, Derek
    DiNella, Jeannine
    Miller, Taylor
    Althouse, Andrew
    Schmidhofer, Mark
    Smith, Roy
    PHARMACOTHERAPY, 2016, 36 (12): : E239 - E239
  • [26] MONITORING HEPARIN-THERAPY BY THE ACTIVATED PARTIAL THROMBOPLASTIN TIME - THE EFFECT OF PREANALYTICAL CONDITIONS
    VANDENBESSELAAR, AMHP
    MEEUWISSEBRAUN, J
    JANSENGRUTER, R
    BERTINA, RM
    THROMBOSIS AND HAEMOSTASIS, 1987, 57 (02) : 226 - 231
  • [27] UNSUITABILITY OF EVACUATED TUBES FOR MONITORING HEPARIN-THERAPY BY ACTIVATED PARTIAL THROMBOPLASTIN TIME
    HEYNS, AD
    VANDENBERG, DJ
    KLEYNHANS, PHT
    DUTOIT, PW
    JOURNAL OF CLINICAL PATHOLOGY, 1981, 34 (01) : 63 - 68
  • [28] ACTIVATED PARTIAL THROMBOPLASTIN TIME MONITORING OF HEPARIN-THERAPY - COMPARISON OF INSTRUMENTS AND REAGENTS
    SEVESO, MP
    MACAGNI, A
    DANGELO, SV
    DETTORI, AG
    BONINI, PA
    DANGELO, A
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 375 - 375
  • [29] Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
    Vandiver, Jeremy W.
    Vondracek, Thomas G.
    PHARMACOTHERAPY, 2012, 32 (06): : 546 - 558